Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Exp Med. Jun 20, 2024; 14(2): 92052
Published online Jun 20, 2024. doi: 10.5493/wjem.v14.i2.92052
Table 1 Clinical characteristics of patients with primary diagnosis of acute pancreatitis, stratified by acute peripancreatic fluid collections on index admission, n (%)
Patient characteristics
Before matching
After matching
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
Total patients638801342583391433914
Age in years at admission, median (IQR)52.0 (39.0, 63.0)49.0 (38.0, 59.0)< 0.00151.0 (39.0, 61.0)49.0 (38.0, 58.0)< 0.001
Age groups (yr)< 0.001< 0.001
    18-33108146 (16.9)5663 (16.5)5716 (16.9)5641 (16.6)
    34-49181354 (28.4)12056 (35.2)10353 (30.5)11962 (35.3)
    50-64200484 (31.4)11619 (33.9)11169 (32.9)11490 (33.9)
    65-79107936 (16.9)4118 (12.0)4895 (14.4)4033 (11.9)
    ≥ 8040881 (6.4)802 (2.3)1781 (5.3)788 (2.3)
Length of stay (days), median (IQR)3.0 (2.0, 5.0)4.0 (3.0, 7.0)< 0.0013.0 (2.0, 5.0)4.0 (3.0, 7.0)< 0.001
Total charges (USD), median (IQR)24238.0 (14623.0, 42043.0)29616.5 (17365.0, 57476.0)< 0.00124418.5 (14865.0, 42640.5)29451.0 (17292.0, 56774.0)< 0.001
30-day readmission37949 (5.9)5363 (15.7)2215 (6.5)5326 (15.7)< 0.001
Elixhauser Comorbidity Index score< 0.0010.093
    049536 (7.8)1366 (4.0)1430 (4.2)1366 (4.0)
    197030 (15.2)3875 (11.3)3994 (11.8)3875 (11.4)
    2131055 (20.5)6353 (18.5)6472 (19.1)6353 (18.7)
    ≥ 3361180 (56.5)22664 (66.2)22018 (64.9)22320 (65.8)
Primary payer< 0.001< 0.001
    Medicare195352 (32.1)7702 (23.8)9348 (29.1)7572 (23.6)
    Medicaid140070 (23.0)9413 (29.1)8332 (25.9)9340 (29.2)
    Private213873 (35.1)11274 (34.8)10763 (33.5)11163 (34.8)
    Other60026 (9.9)3980 (12.3)3697 (11.5)3958 (12.4)
Median household income national quartile for patient ZIP code< 0.0010.005
    1st (0-25th)203221 (32.2)11120 (32.9)11169 (33.3)11002 (32.8)
    2nd (26th-50th)177998 (28.2)9619 (28.4)9373 (28.0)9535 (28.5)
    3rd (51st-75th)148894 (23.6)8093 (23.9)7756 (23.2)8020 (23.9)
    4th (76th-100th)100757 (16.0)5018 (14.8)5199 (15.5)4955 (14.8)
Disposition of patient (uniform)< 0.001< 0.001
    Routine561425 (87.9)28082 (82.0)29204 (86.1)27894 (82.3)
    Transfer to short-term hospital4817 (0.8)753 (2.2)275 (0.8)742 (2.2)
    Transfer other: SNF, ICF, another type of facility17446 (2.7)1392 (4.1)1074 (3.2)1320 (3.9)
    Home health care27211 (4.3)2600 (7.6)1600 (4.7)2540 (7.5)
    Against medical advice25350 (4.0)1209 (3.5)1582 (4.7)1207 (3.6)
Died during hospitalization2386 (0.4)209 (0.6)< 0.001169 (0.5)198 (0.6)0.12
Table 2 Distribution of the Elixhauser comorbidities in patients with acute pancreatitis as a primary diagnosis during index hospitalizations, both before and after matching, stratified by acute peripancreatic fluid collections, n (%)
Factors
Before matching
After matching
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
Total patients638801342583391433914
Congestive heart failure41809 (6.5)1922 (5.6)< 0.0011804 (5.3)1804 (5.3)1.00
Cardiac arrhythmias71251 (11.2)3992 (11.7)0.0043745 (11.0)3909 (11.5)0.047
Valvular disease13556 (2.1)505 (1.5)< 0.001439 (1.3)439 (1.3)1.00
Pulmonary circulation7130 (1.1)482 (1.4)< 0.001380 (1.1)380 (1.1)1.00
Peripheral vascular disease22966 (3.6)1354 (4.0)< 0.0011248 (3.7)1248 (3.7)1.00
Uncomplicated hypertension293986 (46.0)16996 (49.6)< 0.00116804 (49.5)16804 (49.5)1.00
Chronic pulmonary diseases99431 (15.6)5533 (16.2)0.0045264 (15.5)5440 (16.0)0.064
Uncomplicated diabetes90054 (14.1)4365 (12.7)< 0.0014261 (12.6)4261 (12.6)1.00
Complicated diabetes91044 (14.3)4178 (12.2)< 0.0014049 (11.9)4049 (11.9)1.00
Hypothyroidism58431 (9.1)2132 (6.2)< 0.0012028 (6.0)2028 (6.0)1.00
Chronic renal disease55947 (8.8)2114 (6.2)< 0.0012458 (7.2)2063 (6.1)0.088
Liver disease130401 (20.4)8674 (25.3)< 0.0018303 (24.5)8554 (25.2)0.096
PUD excluding bleeding10343 (1.6)634 (1.9)< 0.001582 (1.7)582 (1.7)1.00
HIV/AIDS2063 (0.3)128 (0.4)0.11115 (0.3)115 (0.3)1.00
Rheumatoid arthritis/CVD13799 (2.2)569 (1.7)< 0.001504 (1.5)504 (1.5)1.00
Coagulopathy42399 (6.6)2778 (8.1)< 0.0012667 (7.9)2667 (7.9)1.00
Obesity118599 (18.6)4066 (11.9)< 0.0013946 (11.6)3946 (11.6)1.00
Weight loss34338 (5.4)6255 (18.3)< 0.0016053 (17.8)6053 (17.8)1.00
Fluid and electrolyte disorder251252 (39.3)16382 (47.8)< 0.00116174 (47.7)16174 (47.7)1.00
Blood loss anemia1984 (0.3)211 (0.6)< 0.001119 (0.4)206 (0.6)< 0.001
Iron-deficiency anemia23358 (3.7)2539 (7.4)< 0.0011557 (4.6)2512 (7.4)< 0.001
Alcohol abuse198085 (31.0)17070 (49.8)< 0.00116908 (49.9)16908 (49.9)1.00
Substance abuse57163 (8.9)4181 (12.2)< 0.0014074 (12.0)4074 (12.0)1.00
Tobacco use disorder96674 (15.1)4761 (13.9)< 0.0014616 (13.6)4689 (13.8)0.42
Smoking history4722 (0.7)276 (0.8)0.16199 (0.6)274 (0.8)< 0.001
Psychoses7357 (1.2)471 (1.4)< 0.001418 (1.2)469 (1.4)0.085
Depression93044 (14.6)5899 (17.2)< 0.0015445 (16.1)5804 (17.1)< 0.001
Complicated hypertension72236 (11.3)2941 (8.6)< 0.0013136 (9.2)2836 (8.4)< 0.001
Table 3 Clinical outcomes of patients with a primary diagnosis of acute pancreatitis during index hospitalizations, stratified by acute peripancreatic fluid collections on index admission, n (%)
Clinical outcomes
Before matching
After matching
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
No acute peripancreatic fluid collections
Acute peripancreatic fluid collections
P value
Total patients638801342583391433914
Cholangitis3814 (0.6)164 (0.5)0.005190 (0.6)160 (0.5)0.11
Mechanical ventilation3309 (0.5)669 (2.0)< 0.001300 (0.9)626 (1.8)< 0.001
Nausea13222 (2.1)650 (1.9)0.029752 (2.2)641 (1.9)0.003
Diarrhea15337 (2.4)1089 (3.2)< 0.001898 (2.6)1074 (3.2)< 0.001
Septic shock5693 (0.9)1110 (3.2)< 0.001451 (1.3)1057 (3.1)< 0.001
Portal venous thrombosis4079 (0.6)1521 (4.4)< 0.001265 (0.8)1487 (4.4)< 0.001
Splenic venous thrombosis3194 (0.5)818 (2.39)< 0.001154 (0.5)811 (2.4)< 0.001
ICU level admission3118 (0.5)529 (1.5)< 0.001284 (0.8)496 (1.5)< 0.001
Vasopressor use772 (0.1)138 (0.4)< 0.00170 (0.2)130 (0.4)< 0.001
Acute kidney injury68459 (10.7)3843 (11.2)0.0044038 (11.9)3744 (11.0)< 0.001
New RRT during admission8545 (1.3)434 (1.3)0.27386 (1.1)421 (1.2)0.22
Abdominal pain3070 (0.5)124 (0.4)0.002159 (0.5)120 (0.4)0.019
Jaundice8149 (1.3)1024 (3.0)< 0.001461 (1.4)1013 (3.0)< 0.001
Obstruction of bile duct35968 (5.6)2340 (6.8)< 0.0012259 (6.7)2319 (6.8)0.36
Endoscopic retrograde cholangiography (no intervention)19309 (3.0)395 (1.2)< 0.001740 (2.2)390 (1.1)< 0.001
ERCP biliary with intervention31525 (4.9)1150 (3.4)< 0.0011339 (3.9)1134 (3.3)< 0.001
Endoscopic dilation of ampulla and biliary duct9456 (1.5)253 (0.7)< 0.001413 (1.2)249 (0.7)< 0.001
Endoscopic insertion of stent (tube) into bile duct9784 (1.5)751 (2.2)< 0.001495 (1.5)743 (2.2)< 0.001
Endoscopic removal of stone(s) from biliary tract19161 (3.0)388 (1.1)< 0.001759 (2.2)384 (1.1)< 0.001
Endoscopic biopsy of bile duct2002 (0.3)62 (0.2)< 0.00199 (0.3)62 (0.2)0.004
ERCP pancreatic with intervention6282 (1.0)1107 (3.2)< 0.001323 (1.0)1094 (3.2)< 0.001
Endoscopic insertion of stent (tube) into pancreatic duct5263 (0.8)1005 (2.9)< 0.001278 (0.8)993 (2.9)< 0.001
Endoscopic removal of stone(s) from pancreatic duct1045 (0.2)152 (0.4)< 0.00164 (0.2)150 (0.4)< 0.001
Endoscopic dilation of pancreatic duct583 (0.1)51 (0.1)< 0.00128 (0.1)50 (0.1)0.013